Here are latest patient newsletters from Berkshire West ICP:

The US Food and Drug Administration has released information on the BoiNtech/Pfizer coronavirus vaccine ahead of its meeting to consider emergency certification in the USA. It is noteworthy that the definition of a "case" is quite different from that used for the Oxford/AstraZeneca vaccine so that the claimed efficacies are not comparable. For the BioNtech/Pfizer vaccine a swab is taken when an acute respiratory illness develops. For the Oxford/AstraZeneca vaccine weekly swabs are taken.

A peer-reviewed account of the interim results of the Oxford AstraZeneca Covid-19 vaccine (ChAdOx1) trials has appeared as an article in The Lancet . 23,848 people took part. Analysis of efficacy was based on weekly self-administered postal PCR swab tests in the UK arm of the trial. Altogether 30 participants who had received the vaccine and 101 who received the control had detectable Covid-19.

NHS England has published further details of legislative proposals to put Integrated Care Systems on a statutory basis. 

South Reading Patient Voice is surveying older people in Reading to ask how they find digital access to GP surgeries. We have consulted the Berkshire West CCG on our survey. The work is supported by Berkshire Community Foundation and Reading Voluntary Action. Click to take the survey at https://healthsurvey.uk or here in Urdu at https://healthsurvey.uk/urdu or here in Polish at https://healthsurvey.uk/polskie.